Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Frequently Asked Questions About Meaningful Use: Transport

  1. Can states use the transport messaging system acknowledgement as the final acknowledgement?
  2. Is a list of transport methods available?
  3. Is uploading data in Web Plus a valid transport method?
  4. In the transport document, which category does Web Plus fit under?
  5. Do the meaningful use (MU) rules or the Cancer Implementation Guide require specific transport methods?
  6. Where can I get more information on transport methods?
  7. Will EHR vendors send data via different modules and transport methods for different public health reporting objectives?
  8. Some state PHAs send data to a centralized portal within their state Department of Health (DOH), and the cancer registry retrieves the information from there. Can eMaRC Plus interface with the state DOH portal to retrieve the information?
  9. Have any state cancer registries chosen a transport method?
  10. Many states want an enterprise transport solution. Since immunization requires bidirectional data exchange and cancer registries don’t, should the cancer registry implement a simpler solution?
  1. Can states use the transport messaging system acknowledgement as the final acknowledgement?

Possibly. Methods for fulfilling the acknowledgement requirement are being evaluated.

  1. Is a list of transport methods available?

Yes, please see the Transport Options [PDF-308KB] document.

  1. Is uploading data in Web Plus a valid transport method?

We are exploring the potential of using Web Plus to receive Clinical Document Architecture (CDA) reports securely from another application. Data entry into the Web Plus form would not meet MU requirements because the submitted report would not be in the Health Level Seven (HL7) CDA format.

  1. In the transport document, which category does Web Plus fit under?

It would be a type of Hypertext Transfer Protocol (HTTP)/ Representational State Transfer (REST).

  1. Do the meaningful use (MU) rules or the Cancer Implementation Guide require specific transport methods?

For public health reporting objectives, no transport methods are required by MU rules or the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries [PDF-1.9MB] (commonly called the Cancer Implementation Guide). MU rules require eligible professionals (EPs) and eligible hospitals (EHs) to use the transport technologies specified by their PHA. State cancer registries are encouraged to work with other public health programs that have MU objectives to select a transport method.

  1. Where can I get more information on transport methods?

A summary document is available. Additional guidance is available on PH Connect, and the International Society for Disease Surveillance developed a detailed report on transport mechanisms. [PDF-3.3MB]

  1. Will EHR vendors send data via different modules and transport methods for different public health reporting objectives?

MU rules state that the PHA designates the transport method for vendors to use, so vendors must support multiple methods. Health information exchanges (HIEs) can help by supporting multiple transport methods for providers to submit their data. State PHAs can help by using one transport method between the HIE and the PHA. Kentucky is pilot testing this model.

  1. Some state PHAs send data to a centralized portal within their state Department of Health (DOH), and the cancer registry retrieves the information from there. Can eMaRC Plus interface with the state DOH portal to retrieve the information?

The state DOH can place the files in a folder that is accessible to eMaRC Plus, and eMaRC Plus can be configured to check the folder for new files.

  1. Have any state cancer registries chosen a transport method?

The following states have chosen a transport method:

  • Kentucky is using the Public Health Information Network Messaging System (PHINMS) through the HIE.
  • Maine plans to use the PHINMS, with one route from the largest HIE and another route for providers who are not part of the HIE.
  1. Many states want an enterprise transport solution. Since immunization requires bidirectional data exchange and cancer registries don’t, should the cancer registry implement a simpler solution?

Possibly, but the resources available within the cancer registry should be considered. Some states have a person at the agency level to coordinate efforts. Some agencies would like to have a single hub so that each program does not have to designate a person to monitor the transport system.

 
Contact Us:
  • Centers for Disease Control and Prevention
    Division of Cancer Prevention and Control
    c/o CDC Warehouse
    3719 N Peachtree Rd
    Building 100 MS F-76
    Chamblee GA 30341
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #